People: Arena Pharmaceuticals Inc (ARNA.OQ)
Dr. Preston S. Klassen, M.D., M.H.S. is an Executive Vice President - Research & Development, Chief Medical Officer of the Company. Dr. Klassen has over 20 years of experience in biopharmaceutical product development. Most recently, he was Chief Medical Officer of Laboratoris Sanifit S.L. and prior to that was Executive Vice President, Head of Global Development at Orexigen Therapeutics, Inc. Previously, Dr. Klassen held several positions of increasing responsibility at Amgen Inc., including Therapeutic Area Head for Nephrology. Prior to joining Amgen, he was a faculty member in the Division of Nephrology atDuke UniversityMedical Center. Dr. Klassen received his medical degree from theUniversity of NebraskaCollege of Medicine and completed his residency in internal medicine, fellowship in nephrology, and masters in health sciences degree at Duke University.
|Total Annual Compensation, USD||685,737|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,101,540|
|Fiscal Year Total, USD||1,787,280|